Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,021.00 CHF | -0.49% | +2.73% | +15.41% |
Dec. 09 | GIVAUDAN AG : Gets a Neutral rating from UBS | ZD |
Dec. 03 | Swiss Fragrance Group Givaudan Establishes New Humanitarian Fund | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 6.2B | 6.32B | 6.68B | 7.12B | 6.92B | |||||
Total Revenues | 6.2B | 6.32B | 6.68B | 7.12B | 6.92B | |||||
Cost of Goods Sold, Total | 3.67B | 3.66B | 3.83B | 4.36B | 4.07B | |||||
Gross Profit | 2.53B | 2.66B | 2.86B | 2.76B | 2.85B | |||||
Selling General & Admin Expenses, Total | 1.02B | 1.07B | 1.16B | 1.11B | 1.1B | |||||
R&D Expenses | 528M | 536M | 562M | 522M | 519M | |||||
Other Operating Expenses | 50M | 20M | 29M | 30M | 108M | |||||
Other Operating Expenses, Total | 1.6B | 1.63B | 1.76B | 1.66B | 1.73B | |||||
Operating Income | 931M | 1.03B | 1.1B | 1.1B | 1.11B | |||||
Interest Expense, Total | -70M | -82M | -89M | -95M | -114M | |||||
Interest And Investment Income | 5M | 5M | 8M | 11M | 8M | |||||
Net Interest Expenses | -65M | -77M | -81M | -84M | -106M | |||||
Income (Loss) On Equity Invest. | 4M | 3M | 2M | 11M | 5M | |||||
Currency Exchange Gains (Loss) | -5M | -52M | 43M | 96M | 96M | |||||
Other Non Operating Income (Expenses) | -33M | 15M | -81M | -191M | -111M | |||||
EBT, Excl. Unusual Items | 832M | 920M | 982M | 930M | 998M | |||||
Restructuring Charges | - | -13M | -3M | - | - | |||||
Merger & Related Restructuring Charges | -29M | -25M | -12M | -5M | -3M | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | -4M | -6M | -2M | 3M | -5M | |||||
Asset Writedown | -1M | - | - | - | -1M | |||||
Insurance Settlements | 10M | - | - | - | - | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 808M | 876M | 965M | 928M | 989M | |||||
Income Tax Expense | 106M | 133M | 144M | 72M | 96M | |||||
Earnings From Continuing Operations | 702M | 743M | 821M | 856M | 893M | |||||
Net Income to Company | 702M | 743M | 821M | 856M | 893M | |||||
Net Income - (IS) | 702M | 743M | 821M | 856M | 893M | |||||
Net Income to Common Incl Extra Items | 702M | 743M | 821M | 856M | 893M | |||||
Net Income to Common Excl. Extra Items | 702M | 743M | 821M | 856M | 893M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 76.17 | 80.59 | 89.03 | 92.83 | 96.81 | |||||
Basic EPS - Continuing Operations | 76.17 | 80.59 | 89.03 | 92.83 | 96.81 | |||||
Basic Weighted Average Shares Outstanding | 9.22M | 9.22M | 9.22M | 9.22M | 9.22M | |||||
Net EPS - Diluted | 75.59 | 79.96 | 88.37 | 92.51 | 96.47 | |||||
Diluted EPS - Continuing Operations | 75.59 | 79.96 | 88.37 | 92.51 | 96.47 | |||||
Diluted Weighted Average Shares Outstanding | 9.29M | 9.29M | 9.29M | 9.25M | 9.26M | |||||
Normalized Basic EPS | 56.42 | 62.37 | 66.56 | 63.03 | 67.62 | |||||
Normalized Diluted EPS | 55.99 | 61.88 | 66.06 | 62.82 | 67.39 | |||||
Dividend Per Share | 62 | 64 | 66 | 67 | 68 | |||||
Payout Ratio | 78.63 | 76.85 | 71.74 | 70.91 | 69.09 | |||||
American Depositary Receipts Ratio (ADR) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.2B | 1.33B | 1.4B | 1.37B | 1.36B | |||||
EBITA | 1.05B | 1.18B | 1.25B | 1.21B | 1.21B | |||||
EBIT | 931M | 1.03B | 1.1B | 1.1B | 1.11B | |||||
EBITDAR | 1.22B | 1.35B | 1.42B | 1.38B | 1.37B | |||||
Effective Tax Rate - (Ratio) | 13.12 | 15.18 | 14.92 | 7.76 | 9.71 | |||||
Total Current Taxes | 131M | 170M | 187M | 57M | 158M | |||||
Total Deferred Taxes | -25M | -37M | -43M | 15M | -62M | |||||
Normalized Net Income | 520M | 575M | 614M | 581M | 624M | |||||
Interest on Long-Term Debt | 10M | 10M | - | - | - | |||||
Non-Cash Pension Expense | 7M | 7M | 3M | 3M | 3M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 791M | 848M | 921M | 907M | 897M | |||||
General and Administrative Expenses | 221M | 218M | 239M | 200M | 202M | |||||
Research And Development Expense From Footnotes | 528M | 536M | 562M | 522M | 519M | |||||
Net Rental Expense, Total | 14M | 17M | 18M | 19M | 7M | |||||
Imputed Operating Lease Interest Expense | 2.12M | 2.6M | 2.81M | 2.98M | 1.29M | |||||
Imputed Operating Lease Depreciation | 11.88M | 14.4M | 15.19M | 16.02M | 5.71M | |||||
Stock-Based Comp., Other (Total) | 41M | 56M | 67M | 18M | 29M | |||||
Total Stock-Based Compensation | 41M | 56M | 67M | 18M | 29M |